The clinical stage, PSA level, the Gleason grade, magnetic resonance imaging (MRI), and gene such as PCaA3 and TMPRSS2:ERG have all demonstrated strong associations with the prognosis of PCa patients [5–7]. This evidence concerns the gene KLK3 and posterior cortical atrophy.